Cargando…
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
Genetic lesions in proto-oncogenes result in the perturbation of angiogenesis, the formation of neovessels from a pre-existing microvasculature. Similarly, the subversion of tumor suppressor genes promotes tumor vascularization. Excessive neovessel formation is associated with various neoplasms such...
Autor principal: | Mabeta, Peace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979526/ https://www.ncbi.nlm.nih.gov/pubmed/29652858 http://dx.doi.org/10.3390/ijms19041192 |
Ejemplares similares
-
The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response
por: Favero, Andrea, et al.
Publicado: (2021) -
A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
por: Li Santi, Anna, et al.
Publicado: (2018) -
LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022) -
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
por: Secchi, Massimiliano, et al.
Publicado: (2022) -
PTX3 acts as an extrinsic oncosuppressor
por: Bonavita, Eduardo, et al.
Publicado: (2015)